Latest News & Updates
Breaking News
19 hours ago
Simantini Singh Deo
Other trending news you may like to read
Revagenix Doses First Participant In Phase 1 Trial Of Rev-56 For Non-Cystic Fibrosis Bronchiectasis
Revagenix doses first participant in Phase 1 trial of Rev-56 for non-cystic fibrosis bronchiectasis.
Simantini Singh Deo
Cato Healthcare Supply Appoints Ryan F. Zackon As President And Chief Executive Officer
Cato Healthcare Supply appoints Ryan F. Zackon as President and Chief Executive Officer.
Simantini Singh Deo
Medicus Pharma Receives FDA Clearance To Launch Registrational Phase 2b SkinJect® Trial For Gorlin Syndrome
Medicus Pharma receives FDA clearance to launch registrational Phase 2b SkinJect trial for Gorlin Syndrome.
Simantini Singh Deo
Lexicon Pharmaceuticals Completes Patient Enrolment In Pivotal Phase 3 SONATA-HCM Trial
Lexicon Pharmaceuticals completes patient enrollment in pivotal Phase 3 SONATA-HCM trial.
Simantini Singh Deo
